Rheumatology - European Medical Journal

Continue

Rheumatology

Filter
11 Mins
4 Sep 2018

The Role of Nicotinamide Adenine Dinucleotide in the Pathogenesis of Rheumatoid Arthritis: Potential Implications for Treatment

The aim of this review is to illustrate the role of NAD+-related enzymes in the pathogenesis of RA and highlight the potential therapeutic role of NAD+ in RA.
9 Mins
31 Jul 2018

Anti-TNF in Rheumatic Diseases: Inventory and Outlook

With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…
8 Mins
31 Jul 2018

Editor's Pick: JAK Inhibitors in the Treatment Algorithm of Rheumatoid Arthritis: A Review

Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…
10 Mins
31 Jul 2018

Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge

Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…
9 Mins
31 Jul 2018

Primary Sjögren’s Syndrome in the Elderly: Does Age of Onset Make a Difference?

Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases
10 Mins
31 Jul 2018

Cytokines and Inflammatory Mediators in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a breakdown in immune tolerance
9 Mins
31 Jul 2018

Disease-Modifying Antirheumatic Diets: The New Treatment Modalities for Rheumatoid Arthritis

Autoimmune responses need to be identified and managed promptly to avoid deleterious consequences. Autoimmune diseases, such as rheumatoid arthritis (RA)…
9 Mins
31 Jul 2018

Stroke and Systemic Lupus Erythematosus: A Review

This review analyses the factors responsible for higher ischaemic and haemorrhagic stroke risk in the systemic lupus erythematosus population